Optimization of formulation variables for the development of long acting microsphere based depot injection of olanzapine

Journal of Microencapsulation

Volumn 25, Issue 6, 2008, Pages 426-433

  Nahata, T ^a   Saini, T R ^a  

^a SHRI G S INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Depot injection; Microsphere; Olanzapine; Optimization; PLGA

Indexed keywords

LONG ACTING DRUG; MICROSPHERE; OLANZAPINE; POLYGLACTIN; SODIUM CHLORIDE; SOLVENT; SURFACTANT;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; EVAPORATION; PARTICLE SIZE; PROCESS OPTIMIZATION; PSYCHOSIS; SCHIZOPHRENIA; SURFACE PROPERTY; TEMPERATURE;

BENZODIAZEPINES; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; KINETICS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; SALTS; SEROTONIN UPTAKE INHIBITORS; SOLVENTS; SURFACE-ACTIVE AGENTS; TEMPERATURE;

EID: 49049101138     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040802033913     Document Type: Article

References (17)

1. Al-Maaieh, A. and Flanagan, DR (2001) Salt and co-solvent effect on ionic drug loading into microspheres using an O/W method. J Contr Rel, 70, pp. 169-181.
2. Anderson, A. and Shive, MS (1997) Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 28, pp. 5-24.
3. Bhanji, NH, Chouinard, G. and Margolese, HC (2004) A review of compliance, depot intramuscular antipsychotics and the new long acting injectable atypical antipsychotic risperidone in schizophrenia. Eur Neuropharmacol, 14, pp. 87-92.
4. Dinarvand, R., Moghadam, SH, Sheikhi, A. and Atyabi, F. (2005) Effect of surfactant HLB and different formulation variables on the properties of poly-D, L-lactide microspheres of naltrexone prepared by double emulsion technique. J Microencapsulation, 22, pp. 139-151.
5. Dong, CM, Guo, YZ, Qiu, KY, Gu, ZW and Feng, XD (2005) In vitro degradation and controlled release behavior of D, L-PLGA50 and PCL-b-D, L-PLGA50 copolymer microspheres. J Contr Rel, 107, pp. 53-64.
6. Gilbert, PL, Harris, ML, McAdams, LA and Jaste, DV (1995) Neuroleptic withdrawal in schizophrenic patients: A review of the literature. Arch Gen Psychiatry, 52, pp. 173-188.
7. Jiang, GE, Thanoo, BC and Deluca, P. (2002) Effect of osmotic pressure in the solvent extraction phase on BSA release profile from PLGA microspheres. Pharm Dev Tech, 7, pp. 391-399.
8. Johnson, DA (1984) Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia. J Clin Psychiatry, 45, pp. 13-21.
9. Keith, S. (2006) Advances in psychotropic formulations. Prog Neuro-Psychopharmacol Biol Psychiatry, 30, pp. 996-1008.
10. Kelleher, JP, Centorrino, F., Albert, MJ and Baldessarini, RJ (2002) Advances in atypical antipsychotics for the treatment of schizophrenia: New formulations and new agents. CNS Drugs, 16, pp. 249-261.
11. Lacro, JP, Dunn, LB, Dolder, CR, Lecband, SG and Jaste, DV (2002) Prevalence of risk factors for medications non adherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiatry, 63, pp. 892-909.
12. Littrell, K. and Littrelle, SH (1997) Therapeutic efficacy of olanzapine. J Am Psych Nurses Assoc, 3, pp. S-8-S-12.
13. MacCormack, PL and Wiseman, LR (2004) Olanzapine: A review of its use in the management of bipolar I disorder. Drugs, 64, pp. 2709-2726.
14. Misdrahi, PM, Llorca, C., Lancon, FJ and Bayle, J. (2002) Compliance in schizophrenia: Predictive factors, therapeutical considerations and research implications. Encephale, 28, pp. 266-272.
15. Nose, M., Barbui, C. and Tansella, M. (2003) How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychol Med, 33, pp. 1149-1160.
16. Park, TG (1995) Degradation of poly (lactic-co-glycolic acid) microspheres: Effect of copolymer composition. Biomaterials, 16, pp. 1123-1130.
17. Yamaguchi, K. and Anderson, JM (1993) In vivo compatability of Medisorb 65/35 D-L-lactide/glycolide copolymer microspheres. J Contr Rel, 24, pp. 81-93.